CLC-Ka/b Antibody - FFPE Validated

Skip to product information
1 of 1

BiCell Scientific

SKU:20401-FFPE-50UL

Regular price €500,00 EUR
Regular price Sale price €500,00 EUR
Sale Sold out
Taxes included. Shipping calculated at checkout.
Size
Blocking Peptide
Quantity
View full details

Scientific Overview

This antibody supports experimental designs that assess CLC-Ka/b with interpretable controls and clear contrasts. CLC-Ka/b is a membrane protein linked to solute movement and gradient maintenance. Plan positive and negative controls that match your model system, including perturbations expected to shift the target.

Tracking CLC-Ka/b can clarify whether changes reflect regulation, redistribution, or altered complex assembly.

Research Relevance

Transport targets are commonly studied under stimulation conditions that alter membrane potential, osmolarity, or nutrient availability. Time course design can be decisive when regulation is transient or compartment dependent.

Because cellular networks are interconnected, changes in this target may coincide with shifts in related pathways, trafficking behavior, or structural remodeling. Kidney-focused model systems may monitor this target when evaluating transport, barrier features, or compartment identity.

When building a narrative around the target, it helps to track:

  • patterns consistent with apical or basolateral sorting
  • relative abundance across engineered constructs
  • surface versus intracellular pool distribution

Application-Specific Context

For paraffin-embedded samples, fixation history and retrieval strategy matter; this option is aligned to those constraints. Think about how preparation affects epitope accessibility, and interpret patterns alongside morphology and compartment markers as needed. Align controls to the expected direction of change to support confident interpretation.

When interpreting CLC-Ka/b, consider whether changes track with compartment identity, cell density, or perturbation timing; these factors can influence apparent signal without implying a direct causal link.

The fixed-section format fits designs where CLC-Ka/b is evaluated with deliberate controls and careful comparisons.

Targets:
CLCNKA • CLCNKB
Research Area:
Cardiovascular • Metabolism
Application:
IHC-P
Reactivity:
Human • Mouse • Rat
Host:
Rabbit
Clonality:
Polyclonal
Isotype:
IgG
Immunogen:
Synthetic peptide (14-aa) derived from the C-terminal region of human CLCka/b protein
Conjugation:
Unconjugated
Purification:
Affinity Chromatography
Concentration:
0.25 mg/ml
UniProt:
P51800P51801
Homology:
Synthetic peptide sequence is identical to mouse or rat sequence
Storage Buffer:
PBS, pH 7.2, 0.1% Sodium Azide
Storage Temperature:
-20°C